{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:08:26Z","timestamp":1791299306559,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T00:00:00Z","timestamp":1452470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004364","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T19:09:28Z","timestamp":1452539368000},"page":"e0004364","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["A Rapid Screening Assay Identifies Monotherapy with Interferon-\u00df and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus"],"prefix":"10.1371","volume":"10","author":[{"given":"Stephen D. S.","family":"McCarthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Majchrzak-Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trina","family":"Racine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah N.","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren P.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hoenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P.","family":"Kobinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor N.","family":"Fish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"key":"ref1","unstructured":"World Health Organization, Ebola Situation Report \u2013 16 December 2015. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/ebola\/en\/current-situation\/ebola-situation-report-13-december-2015\" xlink:type=\"simple\">http:\/\/apps.who.int\/ebola\/en\/current-situation\/ebola-situation-report-13-december-2015<\/ext-link>."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1016\/j.vaccine.2014.08.028","article-title":"Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents","volume":"32","author":"G Wong","year":"2014","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"DA Stanley","year":"2014","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"X Qiu","year":"2014","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/cid\/civ420","article-title":"Supportive Care of the First 2 Ebola Virus Disease Patients at the Monrovia Medical Unit","volume":"61","author":"KK Wong","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"L Oestereich","year":"2014","journal-title":"Antiviral Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"TK Warren","year":"2014","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/14787210.2014.948847","article-title":"Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses","volume":"12","author":"DF Florescu","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/JVI.73.3.2333-2342.1999","article-title":"Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems","volume":"73","author":"E Muhlberger","year":"1999","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e0139001","DOI":"10.1371\/journal.pone.0139001","article-title":"Structural Analysis of Monomeric RNA- Dependent Polymerases: Evolutionary and Therapeutic Implications","volume":"10","author":"R J\u00e1come","year":"2015","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1310\/hct0803-164","article-title":"The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naive HIV-1-infected patients","volume":"8","author":"I Cassetti","year":"2007","journal-title":"HIV Clin Trials"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3851\/IMP2497","article-title":"A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine","volume":"17","author":"N Phanuphak","year":"2012","journal-title":"Antivir Ther."},{"key":"ref13","unstructured":"World Health Organization, WHO Model List of Essential Medicines: 18<sup>th<\/sup> list October 2013: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/<\/ext-link>."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/dna.2004.23.783","article-title":"AZT binds RNA at multiple sites","volume":"23","author":"A Ahmed Ouameur","year":"2004","journal-title":"DNA Cell Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/v2010262","article-title":"Evasion of the interferon-mediated antiviral response by filoviruses","volume":"2","author":"WB Cardenas","year":"2010","journal-title":"Viruses"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.chom.2014.07.008","article-title":"Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1","volume":"16","author":"W Xu","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/JVI.01160-10","article-title":"Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway","volume":"85","author":"G Fabozzi","year":"2011","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e1000493","DOI":"10.1371\/journal.ppat.1000493","article-title":"Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery","volume":"5","author":"TH Chang","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/infdis\/jis921","article-title":"Interferon-beta therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever","volume":"208","author":"LM Smith","year":"2013","journal-title":"J Infect Dis"},{"key":"ref20","first-page":"207ra143","article-title":"mAbs and Ad-vectored IFN-alpha therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms","volume":"5","author":"X Qiu","year":"2013","journal-title":"Sci Transl Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1128\/JVI.00173-13","article-title":"Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs","volume":"87","author":"X Qiu","year":"2013","journal-title":"J Virol"},{"key":"ref22","first-page":"52381","article-title":"Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes","volume":"91","author":"T Hoenen","year":"2014","journal-title":"J Vis Exp"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1128\/JVI.01272-14","article-title":"A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity","volume":"88","author":"A Watt","year":"2014","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1586\/14787210.2014.948848","article-title":"Reverse genetics systems as tools for the development of novel therapies against filoviruses","volume":"12","author":"T Hoenen","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"190ra79","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection","volume":"5","author":"LM Johansen","year":"2013","journal-title":"Sci Transl Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"TC Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"290ra89","DOI":"10.1126\/scitranslmed.aaa5597","article-title":"A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity","volume":"7","author":"LM Johansen","year":"2015","journal-title":"Science Transl Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","author":"AS Lok","year":"2003","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1473-3099(14)70937-5","article-title":"Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial","volume":"14","author":"JM Baeten","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1128\/AAC.00419-09","article-title":"Antiretroviral tissue kinetics: in vivo imaging using positron emission tomography","volume":"53","author":"M Di Mascio","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.2042-7158.1998.tb06913.x","article-title":"Pharmacokinetics and tissue distribution of (+\/-)-3&apos;-azido-2&apos;,3&apos;-dideoxy-5&apos;-O-(2-bromomyristoyl)thymidine, a prodrug of 3&apos;-azido-2&apos;,3&apos;-dideoxythymidine (AZT) in mice","volume":"50","author":"K Parang","year":"1998","journal-title":"J Pharm Pharmacol"},{"issue":"Suppl 2","key":"ref32","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1086\/520590","article-title":"In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein","volume":"196","author":"H Ebihara","year":"2007","journal-title":"J Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virol.2010.04.002","article-title":"Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription","volume":"403","author":"T Hoenen","year":"2010","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"23814","DOI":"10.1074\/jbc.M113.476192","article-title":"Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors","volume":"288","author":"S Mehrotra","year":"2013","journal-title":"J Biol Chem"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T21:02:22Z","timestamp":1600030942000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004364"}},"subtitle":[],"editor":[{"given":"Scott C.","family":"Weaver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004364","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,11]]}}}